CVS Health Co. (NYSE:CVS) Shares Purchased by Thematics Asset Management

Thematics Asset Management raised its stake in CVS Health Co. (NYSE:CVS) by 1.9% in the third quarter, HoldingsChannel reports. The institutional investor owned 57,376 shares of the pharmacy operator’s stock after buying an additional 1,064 shares during the quarter. Thematics Asset Management’s holdings in CVS Health were worth $3,608,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the third quarter valued at $25,000. Livelsberger Financial Advisory acquired a new stake in CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC purchased a new position in CVS Health during the 3rd quarter valued at about $32,000. Kathleen S. Wright Associates Inc. acquired a new position in CVS Health during the third quarter worth about $33,000. Finally, First Community Trust NA lifted its holdings in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 2.1 %

CVS traded down $1.27 during trading on Tuesday, reaching $58.81. 1,528,288 shares of the stock traded hands, compared to its average volume of 11,334,237. CVS Health Co. has a fifty-two week low of $52.71 and a fifty-two week high of $83.25. The stock’s 50-day simple moving average is $59.25 and its two-hundred day simple moving average is $58.67. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock has a market cap of $74.01 billion, a price-to-earnings ratio of 15.25, a price-to-earnings-growth ratio of 0.98 and a beta of 0.55.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.21 earnings per share. As a group, equities research analysts expect that CVS Health Co. will post 5.43 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.52%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

CVS has been the subject of a number of analyst reports. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $60.00 to $66.00 in a report on Monday, November 18th. TD Cowen upped their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday. Royal Bank of Canada lowered their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. UBS Group increased their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Finally, Evercore ISI lifted their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $70.33.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.